RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+15.41%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$651M
AUM Growth
+$651M
(+17%)
Cap. Flow
+$51.2M
Cap. Flow
% of AUM
7.86%
Top 10 Holdings %
Top 10 Hldgs %
46.1%
Holding
72
New
24
Increased
13
Reduced
10
Closed
23
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$39.1M |
| 2 |
Amgen
AMGN
|
$38.7M |
| 3 |
STJ
St Jude Medical
STJ
|
$35.3M |
| 4 |
Gilead Sciences
GILD
|
$33.3M |
| 5 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$28.8M |
Top Sells
| 1 |
Align Technology
ALGN
|
$38.8M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$34.2M |
| 3 |
Cardinal Health
CAH
|
$27.6M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$19.2M |
| 5 |
CELG
Celgene Corp
CELG
|
$15.7M |
Sector Composition
| 1 | Healthcare | 82.16% |
| 2 | Consumer Staples | 1.22% |
| 3 | Technology | 0.7% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $39.1M | 5.89% | +271,500 | New | +$39.1M |
|
|
2
Amgen
AMGN
$155B
| $38.7M | 5.83% | +345,700 | New | +$38.7M |
|
|
STJ
3
DELISTED
St Jude Medical
STJ
| $35.3M | 5.32% | +658,000 | New | +$35.3M |
|
|
4
Gilead Sciences
GILD
$140B
| $33.3M | 5.01% | +529,800 | New | +$33.3M |
|
|
CBST
5
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $28.8M | 4.33% | +452,600 | New | +$28.8M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $28.6M | 4.31% | 471,345 -4,032 | -0.8% | -$245K |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $25.2M | 3.79% | 80,400 +19,400 | +32% | +$6.07M |
|
8
Tenet Healthcare
THC
$16.3B
| $24.3M | 3.67% | 591,000 +274,800 | +87% | +$11.3M |
|
|
CTRX
9
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $23.3M | 3.52% | +508,100 | New | +$23.3M |
|
|
ARIA
10
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $23.3M | 3.5% | 1,264,009 -13,100 | -1% | -$241K |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $22.8M | 3.44% | 3,669,593 -1,099,775 | -23% | -$6.84M |
|
12
Insulet
PODD
$23.9B
| $21.7M | 3.27% | 599,000 +25,700 | +4% | +$931K |
|
13
Brookdale Senior Living
BKD
$1.83B
| $19.9M | 3% | 757,800 +211,300 | +39% | +$5.56M |
|
14
Puma Biotechnology
PBYI
$254M
| $18.3M | 2.75% | 340,165 -199,829 | -37% | -$10.7M |
|
15
HCA Healthcare
HCA
$94.5B
| $17.7M | 2.67% | 414,400 -318,900 | -43% | -$13.6M |
|
|
NUVA
16
DELISTED
NuVasive, Inc.
NUVA
| $17M | 2.56% | 693,392 -70,600 | -9% | -$1.73M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $15.2M | 2.29% | 98,600 -102,300 | -51% | -$15.7M |
|
18
Zoetis
ZTS
$69.3B
| $14.5M | 2.18% | +465,900 | New | +$14.5M |
|
|
CMRX
19
DELISTED
Chimerix, Inc.
CMRX
| $14.4M | 2.16% | 653,705 +202,905 | +45% | +$4.46M |
|
20
Cerus
CERS
$251M
| $13.8M | 2.07% | 2,052,400 -373,000 | -15% | -$2.5M |
|
|
HTWR
21
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $13.6M | 2.04% | 185,125 +22,800 | +14% | +$1.67M |
|
22
Globus Medical
GMED
$8.27B
| $12.9M | 1.94% | 736,100 +35,400 | +5% | +$618K |
|
23
Sonida Senior Living
SNDA
$488M
| $12.6M | 1.9% | 597,300 +174,500 | +41% | +$3.69M |
|
24
AstraZeneca
AZN
$248B
| $12.3M | 1.85% | +236,100 | New | +$12.3M |
|
|
ARTC
25
DELISTED
ARTHROCARE CORP
ARTC
| $12.2M | 1.84% | +342,759 | New | +$12.2M |
|